Smirnova, L.A.,
Suchkov, E.A.,
Kuznetsov, K.A.,
Ryabukha, A.F.,
Perfilova, V.N.,
Popova, T.A.,
Tyurenkov, I.N.,
Bychenkova, M.A.,
Latypova, G.M.,
Kataev, V.A. (2021) mM, p
H 4.6), 82:18% (v/v) aqueous to organic phase ratio, 30°C, detection at 205 nm, flow rate 1 m
Gurevich, KG,
Urakov, AL,
Rozit, GA,
Klen, EE,
Samorodov, AV,
Khaliullin, FA (2021) )-1,2,4-triazolyl- 4]acetate (I) by
H2O2. Hydrolysis of esters I and II synthesized 2-[5-bromo-2,4-dihydro- 3-oxo-2
Kataev, V.A.,
Petrova, S.F.,
Perfilova, V.N.,
Murinov, Y.I.,
Bashkatov, S.A.,
Ivanov, S.P.,
Kataev, V.V.,
Agletdinov, E.F. (2021) -DLC). Its metabolite was detected in urine for at least 72
h, which indicated predominant excretion
Khazhiev, SY,
Khusainov, MA,
Khalikov, RA,
Kataev, VA,
Tyumkina, TV,
Meshcheryakova, ES,
Khalilov, LM,
Kuznetsov, VV (2021) for fine organic synthesis and a potential bactericidal compound, was investigated by
H-1 and C-13 NMR